NNDM compared with AUPH: revenue, margins and what each company keeps, and the suppliers and customers both name

NNDMNano Dimension Ltd.

Mkt capRevenueRevenue

AUPHAurinia Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

NNDMNano Dimension Ltd.

AUPHAurinia Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

NNDM1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±25.4%▲+5.18%×0.20

AUPH

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±8.3%▼−3.25%×0.40

Q2 FY26±10.2%▲+6.19%×0.61

= impliedNNDM realized, solidAUPH realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedSource: market data

May 7 '26

±7.5%

▼−6.80%

×0.91

Q1 FY26±10.8%▼−3.19%×0.30

NNDMNano Dimension Ltd.

1.33▲+5.59%· post 1.33

Mkt cap$261.7MRevenue$32MQ3 FY26Revenue—

AUPHAurinia Pharmaceuticals Inc.

16.48▲+1.67%· post 16.48

ClosedNov 6 '26

Mkt cap$2.2BRevenue$84MQ3 FY26Revenue$283MFY25

Compare

ClosedNov 6 '26

NNDMNano Dimension Ltd.

AUPHAurinia Pharmaceuticals Inc.

1.33▲+5.59%post 1.33

Price

16.48▲+1.67%post 16.48

$261.7M

Mkt cap

$2.2B

Q3 FY26$32M

Revenue

$84MQ3 FY26

—

Revenue

$283MFY25

NNDM1.33▲+5.59%vsAUPH16.48▲+1.67%ClosedNov 6 '26